Anthony M Valeri Selected Research

Anthony M Valeri Research Topics

Disease

11	Chronic Kidney Failure (Chronic Renal Failure) 08/2014 - 08/2000
10	Proteinuria 01/2021 - 08/2000
6	Glomerulonephritis 01/2022 - 02/2009
5	Fibrosis (Cirrhosis) 02/2024 - 08/2002
5	Renal Insufficiency (Renal Failure) 01/2022 - 08/2000
5	Hematuria 01/2021 - 01/2009
5	Amyloidosis 01/2018 - 06/2012
3	Atrophy 02/2024 - 08/2002
3	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 09/2008
3	Diabetic Nephropathies (Diabetic Nephropathy) 06/2012 - 01/2008
3	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2009 - 08/2002
2	Arteriosclerosis 06/2012 - 08/2002
2	Hypertension (High Blood Pressure) 04/2003 - 07/2001
1	Hyperoxaluria (Oxaluria) 02/2024
1	Inflammation (Inflammations) 02/2024
1	Fanconi Syndrome (Syndrome, Fanconi) 01/2023
1	Hepatitis 01/2022
1	Amyloid Plaque 01/2022
1	IGA Glomerulonephritis (IGA Nephropathy) 06/2021
1	Sclerosis 01/2021
1	Disease Progression 01/2020
1	COVID-19 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Necrosis 06/2012
1	Heart Failure 05/2012
1	Heart Diseases (Heart Disease) 05/2012
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 05/2012
1	Chronic Renal Insufficiency 05/2012
1	Hypoalbuminemia 08/2010
1	Paraproteinemias (Monoclonal Gammopathy) 09/2009
1	Membranous Glomerulonephritis (Membranous Nephropathy) 02/2009
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2009
1	Nephrogenic Fibrosing Dermopathy 09/2008
1	Hyperphosphatemia 09/2008
1	Benign Familial Hematuria 04/2007
1	Edema (Dropsy) 05/2004
1	Immunoglobulin Light-chain Amyloidosis 07/2001
1	Bipolar Disorder (Manic Depressive Psychosis) 08/2000
1	Cysts 08/2000

Drug/Important Bio-Agent (IBA)

16	CreatinineIBA 01/2021 - 08/2000
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2002
3	Immunoglobulin G (IgG)IBA 01/2023 - 09/2009
3	Congo RedIBA 01/2022 - 01/2018
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 03/2013
2	Chemotactic FactorsIBA 08/2014 - 09/2013
2	Amyloid (Amyloid Fibrils)IBA 09/2013 - 03/2013
1	Calcium OxalateIBA 02/2024
1	OxalatesIBA 02/2024
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 02/2024
1	Rheumatoid FactorIBA 01/2022
1	CryoglobulinsIBA 01/2022
1	Immunoglobulin A (IgA)IBA 06/2021
1	Immune Sera (Antisera)IBA 01/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	ParaffinIBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 08/2014
1	Fibrinogen (Factor I)FDA Link 09/2013
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 09/2013
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2013
1	AA amyloidosisIBA 09/2013
1	ParaproteinsIBA 06/2012
1	Antigen-Antibody Complex (Immune Complex)IBA 09/2009
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2009
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2009
1	GadoliniumIBA 09/2008
1	Contrast MediaIBA 09/2008
1	Formaldehyde (Formol)FDA Link 04/2007
1	Serum AlbuminIBA 05/2004
1	CholesterolIBA 05/2004
1	Angiotensin IIIBA 08/2002
1	1,2,3,4,6,7,8-heptachlorodibenzodioxinIBA 07/2001
1	Mucin-1 (CA 15-3 Antigen)IBA 08/2000
1	LithiumIBA 08/2000
1	LectinsIBA 08/2000

Therapy/Procedure

3	Renal Dialysis (Hemodialysis) 05/2012 - 09/2008
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 08/2014 - 03/2013
2	Therapeutics 01/2009 - 08/2000
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 02/2024
1	Lasers (Laser) 09/2013